- Book
- December 2022
- 384 Pages
- Book
- June 2022
- 336 Pages
- Book
- August 2021
- 432 Pages
- Book
- October 2020
- 384 Pages
- Book
- October 2020
- 432 Pages
- Book
- May 2020
- 300 Pages
- Book
- November 2019
- 368 Pages
- Book
- June 2019
- 304 Pages
- Book
- June 2019
- 496 Pages
- Book
- February 2019
- 288 Pages
- Book
- October 2018
- 240 Pages
- Book
- April 2018
- 200 Pages
- Book
- January 2016
- 472 Pages
- Book
- November 2015
- 776 Pages
- Book
- February 2015
- 400 Pages
- Book
- January 2015
- 464 Pages
- Book
- September 2014
- 1880 Pages
- Book
- August 2014
- 240 Pages
- Book
- February 2014
- 400 Pages
- Book
- November 2013
- 744 Pages
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more